S&P 500   4,027.81 (+1.42%)
DOW   32,717.60 (+1.00%)
QQQ   312.72 (+1.82%)
AAPL   160.77 (+1.98%)
MSFT   280.51 (+1.92%)
META   205.35 (+2.33%)
GOOGL   101.39 (+0.36%)
AMZN   100.25 (+3.10%)
TSLA   193.88 (+2.48%)
NVDA   269.84 (+2.17%)
NIO   9.83 (+6.85%)
BABA   99.92 (+1.54%)
AMD   96.09 (+1.62%)
T   19.00 (+1.50%)
F   12.05 (+3.88%)
MU   63.54 (+7.19%)
CGC   1.81 (+0.00%)
GE   94.06 (+0.99%)
DIS   96.87 (+2.16%)
AMC   5.00 (-2.91%)
PFE   40.25 (+0.65%)
PYPL   74.18 (+2.04%)
NFLX   332.03 (+2.63%)
S&P 500   4,027.81 (+1.42%)
DOW   32,717.60 (+1.00%)
QQQ   312.72 (+1.82%)
AAPL   160.77 (+1.98%)
MSFT   280.51 (+1.92%)
META   205.35 (+2.33%)
GOOGL   101.39 (+0.36%)
AMZN   100.25 (+3.10%)
TSLA   193.88 (+2.48%)
NVDA   269.84 (+2.17%)
NIO   9.83 (+6.85%)
BABA   99.92 (+1.54%)
AMD   96.09 (+1.62%)
T   19.00 (+1.50%)
F   12.05 (+3.88%)
MU   63.54 (+7.19%)
CGC   1.81 (+0.00%)
GE   94.06 (+0.99%)
DIS   96.87 (+2.16%)
AMC   5.00 (-2.91%)
PFE   40.25 (+0.65%)
PYPL   74.18 (+2.04%)
NFLX   332.03 (+2.63%)
S&P 500   4,027.81 (+1.42%)
DOW   32,717.60 (+1.00%)
QQQ   312.72 (+1.82%)
AAPL   160.77 (+1.98%)
MSFT   280.51 (+1.92%)
META   205.35 (+2.33%)
GOOGL   101.39 (+0.36%)
AMZN   100.25 (+3.10%)
TSLA   193.88 (+2.48%)
NVDA   269.84 (+2.17%)
NIO   9.83 (+6.85%)
BABA   99.92 (+1.54%)
AMD   96.09 (+1.62%)
T   19.00 (+1.50%)
F   12.05 (+3.88%)
MU   63.54 (+7.19%)
CGC   1.81 (+0.00%)
GE   94.06 (+0.99%)
DIS   96.87 (+2.16%)
AMC   5.00 (-2.91%)
PFE   40.25 (+0.65%)
PYPL   74.18 (+2.04%)
NFLX   332.03 (+2.63%)
S&P 500   4,027.81 (+1.42%)
DOW   32,717.60 (+1.00%)
QQQ   312.72 (+1.82%)
AAPL   160.77 (+1.98%)
MSFT   280.51 (+1.92%)
META   205.35 (+2.33%)
GOOGL   101.39 (+0.36%)
AMZN   100.25 (+3.10%)
TSLA   193.88 (+2.48%)
NVDA   269.84 (+2.17%)
NIO   9.83 (+6.85%)
BABA   99.92 (+1.54%)
AMD   96.09 (+1.62%)
T   19.00 (+1.50%)
F   12.05 (+3.88%)
MU   63.54 (+7.19%)
CGC   1.81 (+0.00%)
GE   94.06 (+0.99%)
DIS   96.87 (+2.16%)
AMC   5.00 (-2.91%)
PFE   40.25 (+0.65%)
PYPL   74.18 (+2.04%)
NFLX   332.03 (+2.63%)
NASDAQ:HOLX

Hologic - HOLX Earnings Date, Estimates & Call Transcripts

$79.20
+0.37 (+0.47%)
(As of 03/29/2023 05:11 PM ET)
Add
Compare
Today's Range
$78.40
▼
$79.39
50-Day Range
$77.07
▼
$86.16
52-Week Range
$59.78
▼
$86.65
Volume
1.11 million shs
Average Volume
1.62 million shs
Market Capitalization
$19.53 billion
P/E Ratio
20.20
Dividend Yield
N/A
Price Target
$84.08

Earnings Summary

Upcoming
Earnings Date
Apr. 26Estimated
Actual EPS
(Feb. 1)
$1.07 Beat By $0.17
Consensus EPS
(Feb. 1)
$0.90
Last Year's Q1 EPS
(2/2/2022)
$2.17
Read Call Transcript
Listen to Call
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

HOLX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

HOLX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Hologic Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20232$0.86$0.96$0.91$0.90 -
Q2 20232$0.87$0.89$0.88$0.80 - $0.90
Q3 20232$0.83$0.86$0.85 
Q4 20232$0.92$0.94$0.93 
FY 20238$3.48$3.65$3.57 
Q1 20242$1.03$1.13$1.08 
Q2 20242$0.92$0.99$0.96 
Q3 20242$0.94$0.98$0.96 
Q4 20242$1.02$1.05$1.04 
FY 20248$3.91$4.15$4.03 
Q1 20251$1.05$1.05$1.05 

HOLX Earnings Date and Information

Hologic last released its quarterly earnings results on February 1st, 2023. The medical equipment provider reported $1.07 earnings per share for the quarter, topping analysts' consensus estimates of $0.90 by $0.17. The firm had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.01 billion. Its revenue was down 27.0% compared to the same quarter last year. Hologic has generated $3.92 earnings per share over the last year ($3.92 diluted earnings per share) and currently has a price-to-earnings ratio of 20.2. Earnings for Hologic are expected to grow by 6.68% in the coming year, from $3.74 to $3.99 per share. Hologic has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 26th, 2023 based off prior year's report dates.

Hologic Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
4/26/2023
(Estimated)		        
2/1/2023Q1 23$0.90$1.07+$0.17$1.39$1.01 billion$1.07 billion    
10/31/2022Q4 2022$0.62$0.82+$0.20$1.17$861.68 million$953.30 million    
7/27/2022Q3 2022$0.69$0.95+$0.26$1.00$896.71 million$1.00 billion    
4/27/2022Q2 2022$1.55$2.07+$0.52$2.34$1.28 billion$1.44 billion      
2/2/2022Q1 2022$1.20$2.17+$0.97$2.39$1.21 billion$1.47 billion    
10/31/2021Q4 2021$1.01$1.61+$0.60$1.94$1.04 billion$1.32 billion    
7/28/20216/30/2021$1.12$1.33+$0.21$1.62$1.03 billion$1.17 billion    
4/28/20213/31/2021$2.62$2.59($0.03)$2.80$1.54 billion$1.54 billion  
1/27/202112/31/2020$2.14$2.86+$0.72$3.22$1.39 billion$1.61 billion    
11/4/20209/30/2020$1.22$2.07+$0.85$2.26$1.11 billion$1.35 billion  
7/29/20206/30/2020$0.38$0.75+$0.37$0.97$622.96 million$822.90 million  
4/29/20203/31/2020$0.57$0.57$0.78$756.10 million$756.10 million  
1/29/2020Q1 2020$0.61$0.61($0.21)$849.40 million$850.50 million  
11/6/2019Q4$0.65$0.65$1.15$846.54 million$865.80 million  
7/31/2019Q3$0.61$0.63+$0.02$0.91$836.91 million$852.40 million  
5/1/2019Q2 2019$0.57$0.58+$0.01$2.17$806.99 million$818.40 million  
1/30/201912/31/2018$0.57$0.58+$0.01$0.80$823.22 million$830.70 million    
11/7/20189/30/2018$0.59$0.58($0.01)$0.98$808.63 million$813.50 million  
7/31/2018Q3 2018$0.56$0.58+$0.02$0.75$800.14 million$824.00 million  
5/2/2018Q2 2018$0.53$0.53$3.52$781.23 million$789.30 million  
2/8/2018Q1 2018$0.50$0.55+$0.05($0.35)$785.80 million$791.10 million    
11/8/2017Q4 2017$0.49$0.50+$0.01$0.71$792.54 million$802.90 million
8/2/2017Q3 2017$0.49$0.50+$0.01$0.79$799.70 million$806.10 million  
5/10/2017Q2 17$0.46$0.50+$0.04($0.84)$685.24 million$715.40 million
2/1/2017Q117$0.51$0.52+$0.01$0.74$725.01 million$734.40 million  
11/2/2016Q416$0.50$0.52+$0.02$0.71$721.52 million$726.80 million
7/27/2016Q316$0.48$0.51+$0.03$0.72$703.66 million$717.40 million  
4/27/2016Q216$0.46$0.47+$0.01$0.70$686.82 million$693.30 million  
1/27/2016Q116$0.42$0.46+$0.04$0.63$688.68 million$695.20 million  
11/4/2015Q415$0.42$0.43+$0.01$0.77$691.94 million$702.80 million  
7/29/2015Q315$0.39$0.43+$0.04$0.76$653.85 million$693.90 million  
4/29/2015Q215$0.39$0.41+$0.02$0.65$646.49 million$655.50 million
1/28/2015Q115$0.36$0.39+$0.03$0.68$630.79 million$652.80 million  
11/5/2014Q414$0.37$0.43+$0.06$0.76$636.20 million$660.60 million  
7/30/2014Q314$0.34$0.37+$0.03$0.70$621.89 million$632.60 million  
4/30/2014Q214$0.33$0.37+$0.04$0.80$609.35 million$625.00 million  
2/3/2014Q1 2014$0.31$0.34+$0.03$0.70$609.65 million$612.40 million  
11/11/2013Q4 2013$0.37$0.39+$0.02$4.89$624.40 million$622.10 million  
8/5/2013Q3 2013$0.37$0.38+$0.01$0.80$627.05 million$626.10 million  
5/6/2013Q2 2013$0.34$0.35+$0.01$0.89$639.53 million$619.10 million  
2/4/2013Q1 2013$0.37$0.38+$0.01$646.52 million$644.60 million  
11/12/2012Q412$0.36$0.37+$0.01$581.12 million$600.20 million  
7/30/2012$0.34$0.35+$0.01
4/30/2012$0.33$0.33  
1/30/2012$0.32$0.34+$0.02
11/7/2011$0.33$0.34+$0.01  
8/1/2011$0.32$0.32
5/2/2011$0.28$0.30+$0.02
1/31/2011$0.28$0.30+$0.02
11/8/2010Q4 2010$0.30$0.30$1.13
8/2/2010Q3 2010$0.29$0.30+$0.01$0.50
5/3/2010Q2 2010$0.29$0.29$0.50
2/1/2010Q1 2010$0.26$0.29+$0.03$0.48
11/9/2009Q4 2009$0.26$0.28+$0.02$0.43
8/3/2009Q3 2009$0.26$0.29+$0.03$0.42
5/4/2009Q2 2009$0.27$0.29+$0.02$9.55
2/2/2009Q1 2009$0.30$0.31+$0.01$0.43
11/11/2008Q4 2008$0.30$0.30$1.16
7/30/2008Q3 2008$0.29$0.33+$0.04$0.42
5/1/2008Q2 2008$0.28$0.29+$0.01$0.36
1/31/2008Q1 2008$0.23$0.25+$0.02$2.15












Hologic Earnings - Frequently Asked Questions

When is Hologic's earnings date?

Hologic has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 26th, 2023 based off last year's report dates. Learn more on HOLX's earnings history.

Did Hologic beat their earnings estimates last quarter?

In the previous quarter, Hologic (NASDAQ:HOLX) reported $1.07 earnings per share (EPS) to beat the analysts' consensus estimate of $0.90 by $0.17. Learn more on analysts' earnings estimate vs. HOLX's actual earnings.

How can I listen to Hologic's earnings conference call?

The conference call for Hologic's latest earnings report can be listened to online. Listen to Conference Call

How can I read Hologic's conference call transcript?

The conference call transcript for Hologic's latest earnings report can be read online. Read Transcript

How much revenue does Hologic generate each year?

Hologic (NASDAQ:HOLX) has a recorded annual revenue of $4.86 billion.

How much profit does Hologic generate each year?

Hologic (NASDAQ:HOLX) has a recorded net income of $1.30 billion. HOLX has generated $3.92 earnings per share over the last four quarters.

What is Hologic's price-to-earnings ratio?

Hologic (NASDAQ:HOLX) has a trailing price-to-earnings ratio of 20.20 and a forward price-to-earnings ratio of 21.18. The price/earnings-to-growth ratio is 1.39.

What is Hologic's EPS forecast for next year?

Hologic's earnings are expected to grow from $3.74 per share to $3.99 per share in the next year, which is a 6.68% increase.

More Earnings Resources from MarketBeat

Earnings Tools:
Earnings By Country:
Latest Articles:
Upcoming Earnings:
This page (NASDAQ:HOLX) was last updated on 3/29/2023 by MarketBeat.com Staff